Skip to main content
. 2017 Dec 1;50(1):98–105. doi: 10.1093/abbs/gmx127

Figure 1.

Figure 1.

Normal and altered Smad4 signaling (A) Canonical TGF-β signaling in normal cells or stromal cells. (B) Smad4 loss in tumor epithelia causes compensatory TGF-β overproduction that signals through Smad2/3 in tumor cells and paracrine TGF-β signaling in stromal cells through Smad2/3/4. TGF-β signaling can be blocked by a TGF-βRI inhibitor.